A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus (ELEMENT 5)
I4L-MC-ABER - ClinicalTrials.gov - NCT02302716
The main purpose of this study is to evaluate the safety and efficacy of the study drug known as LY2963016 as compared to LANTUS® in adults with type 2 diabetes mellitus who are on 2 or more oral antihyperglycemic medications (OAMs).
Trial Summary
Age Range
≥18 yearsConditions the trial is for
Type 2 DiabetesWhat the trial is testing?
LY2963016, Insulin GlargineCould I receive a Placebo?
NoEnrollment Goal
493Trial Dates
Dec 1, 2014 - Jul 1, 2016How long will I be in the trial?
Your participation in this trial could last up to 28 weeks and include 9 visits to the study center.Trial Phase
IIILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo